Jens Niewoehner

USPTO Granted Patents = 25 (Patent Applications = 1)

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 66(Granted Patents)

Location History:

Penzberg, DE (2021)
Munich, DE (2012 - 2023)

Company Filing History:

23 out of 4,942

Hoffmann-la Roche Inc.

Prothena Bioscience Limited

patent

where one patent can have more than one assignee

Years Active: 2012-2025

where 'Filed Patents' based on already Granted Patents

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12331134 - Trispecific antibodies specific for HER2 and a blood brain barrier receptor and methods of use (2025-06-17),

2. 12297263 - Humanized anti-Tau(PS422) antibodies and methods of use (2025-05-13),

3. 12252533 - Anti-transferrin receptor antibodies with tailored affinity (2025-03-18),

4. 12129306 - Antibodies binding to STEAP-1 (2024-10-29),

5. 11685790 - Antibodies binding to STEAP-1 (2023-06-27),

6. 11584793 - Anti-transferrin receptor antibodies with tailored affinity (2023-02-21),

7. 11572404 - Humanized anti-Tau(pS422) antibodies and methods of use (2023-02-07),

8. 11273223 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles (2022-03-15),

9. 11180571 - Antibodies binding to STEAP-1 (2021-11-23),

10. 11098338 - Recombinant polypeptide production methods (2021-08-24),

11. 10822402 - Humanized anti-tau(pS422) antibodies and methods of use (2020-11-03),

12. 10806795 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles (2020-10-20),

13. 10562973 - Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein (2020-02-18),

14. 10561737 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles (2020-02-18),

15. 10370692 - Recombinant polypeptide production methods (2019-08-06),

Title: Innovations and Contributions of Jens Niewoehner in the Field of Antibody Research

Introduction

Jens Niewoehner, based in Munich, Germany, is a prominent figure in the field of biopharmaceuticals, particularly known for his groundbreaking work in antibody research. With an impressive portfolio of 24 patents, Niewoehner has made significant contributions that advance therapeutic developments.

Latest Patents

Among his latest innovations are the "Humanized anti-Tau(PS422) antibodies and methods of use," which provide humanized antibody solutions targeting the human Tau protein. This advancement opens possibilities for therapeutic interventions in neurodegenerative diseases. Additionally, he has developed "Anti-transferrin receptor antibodies with tailored affinity," which reports on an antibody that binds specifically to both human and cynomolgus transferrin receptors, showcasing a refinement in antibody affinity and efficacy determined through surface plasmon resonance.

Career Highlights

Niewoehner has worked with leading companies in the biotech sector, including Hoffmann-La Roche Inc. and U3 Pharma GmbH. His career is marked by his relentless pursuit of innovations that not only advance scientific understanding but also commercial viability in therapeutic solutions.

Collaborations

Throughout his career, Jens Niewoehner has collaborated with esteemed colleagues, including Guy Georges and Ekkehard Moessner. These partnerships have fostered an environment of shared expertise, further enhancing the impact of his research and inventions.

Conclusion

Jens Niewoehner’s contributions to antibody research illustrate the potential of innovations in improving treatments for complex diseases. His latest patents reflect a deep commitment to scientific advancement and the hope for therapeutic breakthroughs that could benefit patients worldwide. As his career progresses, the impact of his inventions will continue to be significant in the biopharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.